Press Releases

Northwest Biotherapeutic, a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced commencement of production of its first dendritic cell cancer vaccine for a compassionate use patient at its recently licensed production facility in Sawston, UK. This...

ImmunoGen Inc., a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, announced a global, multi-year definitive licensing agreement whereby it granted Eli Lilly and Company (Lilly) exclusive rights to research, develop, and commercialize...

Peli BioThermal, the life science industry’s cold chain partner from discovery to distribution, announces its newest version of Credo™ Cargo, a key component of the Credo™ on Demand rental program. The new version includes an anti-tampering system for the...

The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, is announcing the launch of a new project on the microbiome, which could help speed up the advancement of new, precision medicines and...

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced plans to expand its commercial network across six additional countries in Europe. Moderna plans to establish a commercial presence in Belgium, Denmark, Norway, the Netherlands, Poland,...

BioNTech SE has taken a next step to improve vaccine supply in Africa. The company has introduced its approach to establishing scalable vaccine production by developing and delivering turnkey mRNA manufacturing facilities based on a container solution. At a...

Catalent, the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, announced that it plans to expand its Waigaoqiao Free Trade Zone (FTZ) facility...